Swiss stocks - Factors to watch on Jan 7

ZURICH Mon Jan 7, 2013 12:48am EST

ZURICH Jan 7 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Monday.


Swiss pharmaceutical group Roche is no longer considering a bid for U.S. gene-sequencing company Illumina ILMN.O, Chairman Franz Humer was quoted as saying in a newspaper interview on Sunday.

For related news click on


* Swiss chief finance diplomat Michael Ambuehl was given a verbal pledge from the U.S. Department of Justice to respect Swiss law when asking for bank client data of potential tax dodgers, a newspaper reported on Sunday.

* Swiss banks are whispering a silent prayer that the deal between private banker Wegelin & Co and Washington over tax dodging could smoothe the way to cheaper and faster settlements of their own cases with U.S. authorities.

* The U.S. government has raised the stakes in its crackdown on Swiss banks through a hard-charging prosecution that has forced the closing of a 272-year-old Swiss firm for offering tax-evasion services to wealthy Americans.

For related news click on [CSGN.VX RTRS TAX]


Swiss Life's German advisory unit AWD, which was recently rebranded Swiss Life Select, has missed its 2012 profit targets, a German magazine said, citing sources close to Swiss Life.

For related news click on



* Preliminary IMF data on the SNB's foreign currency reserves due at 0800 GMT.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.